These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18633234)

  • 61. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
    Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
    Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer.
    Yeh KH; Lu YS; Hsu CH; Lin JF; Hsu C; Kuo SH; Li SJ; Cheng AL
    Oncology; 2005; 69(1):88-95. PubMed ID: 16088236
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [A Patient with Gastric Cancer with Peritoneal Dissemination Who Survived for Five Years after Sequential Chemotherapy with S-1 Followed by Paclitaxel].
    Urano S; Kakiuchi Y; Takashima H
    Gan To Kagaku Ryoho; 2016 Feb; 43(2):251-4. PubMed ID: 27067693
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice.
    Ohashi N; Kodera Y; Nakanishi H; Yokoyama H; Fujiwara M; Koike M; Hibi K; Nakao A; Tatematsu M
    Int J Oncol; 2005 Sep; 27(3):637-44. PubMed ID: 16077911
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor].
    Nakayama N; Tanabe S; Koizumi W; Higuchi K; Sasaki T; Nakatani K; Shimoda T; Nishimura K; Kobayashi N; Mitomi H; Saigenji K
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1641-4. PubMed ID: 17108732
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [A case of long-term survival of gastric cancer with peritoneal metastasis effectively treated by TS-1 and paclitaxel (PTX) combination therapy].
    Tanaka K; Kanamaru T; Yamamoto M
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):993-6. PubMed ID: 16835495
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Weekly administration of paclitaxel with a short course of premedication for advanced or recurrent gastric cancer].
    Yamamoto S; Tanaka Y; Ito T; Nakai S; Morimoto Y; Kitagawa T; Kurihara Y; Nishimura J
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):67-71. PubMed ID: 12557707
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Weekly administration of paclitaxel might be beneficial against TS-1-resistant recurrent gastric cancer--a case report].
    Tsubono M; Kaneko I; Kii E; Tanaka T; Murata T; Kamimura K; Kida A
    Gan To Kagaku Ryoho; 2004 Aug; 31(8):1237-41. PubMed ID: 15332551
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [A recurrent gastric cancer with peritoneal metastasis 15 years after distal gastrectomy successfully treated with S-1 and weekly intravenous and intraperitoneal injections of Paclitaxel].
    Iwai N; Wakabayashi N; Matsumoto N; Morita Y; Tanaka N; Yoriki H; Fujii K; Takada R; Takaya H; Masuzawa A; Takami S; Kataoka K
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):351-4. PubMed ID: 25812506
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [A case of unresectable advanced gastric cancer treated with S-1/low-dose CDDP combination chemotherapy through jejunostomy].
    Sonoda H; Hamada J; Shimomura K; Itokawa Y; Ikeda J; Taniguchi F; Ueshima Y; Takashina K; Lee C; Shioaki Y
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1179-81. PubMed ID: 21772107
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Long-term disease-free survival by S-1 therapy in a case of gastric cancer with peritoneal dissemination].
    Yamamoto M; Osaki T; Kuroda H; Nagai S; Watanabe H; Takahashi S; Kurisu Y; Ikeguchi M
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1417-9. PubMed ID: 25434446
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Kondo K; Kobayashi M; Kojima H; Hirabayashi N; Kataoka M; Araki K; Matsui T; Takiyama W; Miyashita Y; Nakazato H; Nakao A; Sakamoto J
    Jpn J Clin Oncol; 2005 Jun; 35(6):332-7. PubMed ID: 15961435
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [A case of scirrhous gastric cancer with peritoneal dissemination acquiring stable disease over three years by treatment with oral anticancer drug S-1].
    Tanabe D; Kondou K; Uchiyama T; Noda K
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1391-3. PubMed ID: 18701856
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [A Case of Long-Term Survival of a Patient with Gastric Cancer with Peritoneal Dissemination].
    Nakao K; Shitara K; Fukunari H; Yamamoto Y; Kato T; Okajima C; Hayashi T; Watanabe G
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2000-2. PubMed ID: 26805244
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [A case of advanced gastric cancer with peritoneal dissemination effectively treated by combined chemotherapy of paclitaxel (TXL) and TS-1].
    Kuriyama H; Nonaka T; Sawatari T; Tsuboi H; Akanuma M; Hata Y
    Gan To Kagaku Ryoho; 2005 May; 32(5):663-5. PubMed ID: 15918568
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T
    Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neoadjuvant treatment of gastric cancer with peritoneal dissemination.
    Yonemura Y; Bandou E; Sawa T; Yoshimitsu Y; Endou Y; Sasaki T; Sugarbaker PH
    Eur J Surg Oncol; 2006 Aug; 32(6):661-5. PubMed ID: 16621433
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [A case responding to weekly paclitaxel (TXL) therapy as third line chemotherapy for scirrhous type gastric cancer].
    Sagawa T; Tsuji Y; Takayanagi N; Hirayama Y; Sakamaki S; Chiba H; Nakajima T; Iyama S; Oku T; Sumiyoshi T; Sato Y; Takahashi M; Takayama T; Niitsu Y
    Gan To Kagaku Ryoho; 2003 May; 30(5):707-10. PubMed ID: 12795107
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Antitumor effect of paclitaxel for gastric cancer is AUC dependent].
    Yamada T; Tanaka N; Furukawa K; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Katsuta M; Ohaki Y; Tajiri T
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):251-3. PubMed ID: 18281760
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phase I and pharmacological study of single paclitaxel administered weekly for heavily pre-treated patients with epithelial ovarian cancer.
    Takano M; Kikuchi Y; Kita T; Suzuki M; Ohwada M; Yamamoto T; Yamamoto K; Inoue H; Shimizu K
    Anticancer Res; 2002; 22(3):1833-8. PubMed ID: 12168878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.